Results 111 to 120 of about 1,782,711 (374)

A temporal model for multiple sclerosis course evolution [PDF]

arXiv, 2016
Multiple Sclerosis is a degenerative condition of the central nervous system that affects nearly 2.5 million of individuals in terms of their physical, cognitive, psychological and social capabilities. Researchers are currently investigating on the use of patient reported outcome measures for the assessment of impact and evolution of the disease on the
arxiv  

CLINICAL DIAGNOSIS OF THE SYPHILOGENOUS DISEASES OF THE CENTRAL NERVOUS SYSTEM [PDF]

, 1909
M. Nonne
openalex   +1 more source

SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The impact of SARS‐CoV‐2 infection on brain and spinal cord pathology in patients with multiple sclerosis (pwMS) remains unclear. We aimed to describe changes in brain lesion activity and brain and spinal cord volumes following SARS‐CoV‐2 infection.
Tomas Uher, Dominika Stastna, Ingrid Menkyova, Vaclav Capek, Jiri Lindner, Petra Nytrova, Jan Krasensky, Eliza Varju, Miguel D'haeseleer, Eva Kubala Havrdova, Dana Horakova, Manuela Vaneckova, Niels Bergsland   +12 more
wiley   +1 more source

Auditory pathway abnormalities in Parkinson's disease

Arquivos de Neuro-Psiquiatria
Background Parkinson's disease (PD) is a degenerative, progressive, chronic disease that mainly affects the central nervous system, caused by dopamine deficiency.
Rafaela Valiengo de Souza, Liliane Aparecida Fagundes Silva, Carla Gentile Matas   +2 more
doaj   +1 more source

Observations on the ALTERATION OF THE CIRCULATION OF THE BRAIN BY SURGICAL MEANS IN DISEASES OF THE CENTRAL NERVOUS SYSTEM [PDF]

, 1932
N. D. Royle
openalex   +1 more source

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan, María A. Piedrabuena, María A. Zarate, Sofía Rodríguez Murúa, Ezequiel I. Surace, Mauricio F. Farez, Marcela P. Fiol, María C. Ysrraelit, Jorge Correale   +8 more
wiley   +1 more source

A reaction-diffusion model for the progression of Parkinson's disease [PDF]

arXiv, 2017
The temporal and spatial development of Parkinson's disease has been characterised as the progressive formation of {\alpha}-synuclein aggregations through susceptible neuronal pathways. This article describes a new model for this progression mechanism in which Parkinsonian damage moves over time through the nervous system by the combined effect of the ...
arxiv  

ON CERTAIN CASES OF DISEASE OF THE CENTRAL NERVOUS SYSTEM IN WHICH NO NAKED-EYE CHANGES ARE FOUND AT THE POST-MORTEM EXAMINATION. [PDF]

, 1885
SeymourJ. Sharkey
openalex   +1 more source

Effects of Pharmacologic and Nonpharmacologic Interventions for the Management of Sleep Problems in People With Fibromyalgia: Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials

Arthritis Care &Research, EarlyView.
Objective Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain and fatigue. Almost everyone with fibromyalgia has sleep problems. We aimed to evaluate the effectiveness and safety of current interventions for the management of fibromyalgia‐related sleep problems.
Jemma Hudson, Mari Imamura, Clare Robertson, Daniel Whibley, Lorna Aucott, Katie Gillies, Paul Manson, Debra Dulake, Abhishek Abhishek, Nicole K. Y. Tang, Gary J. Macfarlane, Miriam Brazzelli   +11 more
wiley   +1 more source

A CASE OF IDIOCY WITH UNIVERSAL RIGIDITY, THE RESULT OF SYPHILITIC DISEASE OF THE CENTRAL NERVOUS SYSTEM [PDF]

, 1884
Angel Money
openalex   +1 more source